@article{CDT13089,
author = {Shivanshu Madan and Shenil Shah and Patrick Dale and Sasan Partovi and Sahil A. Parikh},
title = {Use of novel oral anticoagulant agents in venous thromboembolism},
journal = {Cardiovascular Diagnosis and Therapy},
volume = {6},
number = {6},
year = {2016},
keywords = {},
abstract = {New oral anticoagulants (NOAC) serve as alternatives for patients currently using warfarin for the prevention and treatment of venous thromboembolic (VTE) disease. This article provides a brief summary of the clinical use of these drugs as well as a review of the landmark clinical trials which evaluated described their safety and efficacy. As more data becomes available, a fundamental understanding of these medications will be vital to cardiovascular practitioners managing patients with VTE.},
issn = {2223-3660}, url = {https://cdt.amegroups.org/article/view/13089}
}